- Home
- INZY vs MVST Comparison
INZY vs MVST Comparison
Compare INZY & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- MVST
- Stock Information
- Founded
- INZY 2015
- MVST 2006
- Country
- INZY United States
- MVST United States
- Employees
- INZY N/A
- MVST N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- MVST Industrial Machinery/Components
- Sector
- INZY Health Care
- MVST Miscellaneous
- Exchange
- INZY Nasdaq
- MVST Nasdaq
- Market Cap
- INZY 188.2M
- MVST 182.8M
- IPO Year
- INZY 2020
- MVST N/A
- Fundamental
- Price
- INZY $1.41
- MVST $2.18
- Analyst Decision
- INZY Strong Buy
- MVST Buy
- Analyst Count
- INZY 8
- MVST 3
- Target Price
- INZY $17.75
- MVST $3.33
- AVG Volume (30 Days)
- INZY 870.7K
- MVST 17.4M
- Earning Date
- INZY 03-11-2025
- MVST 11-12-2024
- Dividend Yield
- INZY N/A
- MVST N/A
- EPS Growth
- INZY N/A
- MVST N/A
- EPS
- INZY N/A
- MVST N/A
- Revenue
- INZY N/A
- MVST $370,989,000.00
- Revenue This Year
- INZY N/A
- MVST $19.19
- Revenue Next Year
- INZY N/A
- MVST $29.35
- P/E Ratio
- INZY N/A
- MVST N/A
- Revenue Growth
- INZY N/A
- MVST 39.03
- 52 Week Low
- INZY $1.24
- MVST $0.15
- 52 Week High
- INZY $7.80
- MVST $2.87
- Technical
- Relative Strength Index (RSI)
- INZY 24.92
- MVST 56.49
- Support Level
- INZY $1.24
- MVST $1.92
- Resistance Level
- INZY $1.44
- MVST $2.30
- Average True Range (ATR)
- INZY 0.25
- MVST 0.28
- MACD
- INZY -0.07
- MVST -0.06
- Stochastic Oscillator
- INZY 9.00
- MVST 34.29
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extend from core battery chemistry to battery packs.